Milvus Empowers AI Drug Development
The field of new drug development has long been known for its lengthy timelines, high costs, significant risks, and low return on investment. The average development cost for a new drug has reached $2.6 billion, with an average time frame of ten years. Despite such high R&D costs and prolonged timelines, there is no guarantee … Read more